AU Patent

AU2013200554A1 — Extended release compositions

Assigned to GENERIC PARTNERS PTY Ltd · Expires 2013-08-22 · 13y expired

What this patent protects

Abstract Provided are controlled release pharmaceutical compositions comprising desvenlafaxine oxalate, one or more release rate controlling polymers, and pharmaceutically acceptable 5 excipients.

USPTO Abstract

Abstract Provided are controlled release pharmaceutical compositions comprising desvenlafaxine oxalate, one or more release rate controlling polymers, and pharmaceutically acceptable 5 excipients.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013200554A1
Jurisdiction
AU
Classification
—
Expires
2013-08-22
Drug substance claim
No
Drug product claim
No
Assignee
GENERIC PARTNERS PTY Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.